Koor Q3 net profit rises 74%

Chief Executive Jonathan Kolber said the company was looking to expand its portfolio.

By YIGAL GRAYEFF, AVI KRAWITZ
November 24, 2005 08:29

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Koor Industries' third-quarter net profit rose 74 percent after improved performances at portfolio companies Makhteshim Agan Industries and ECI Telecom. The holding company said on Wednesday that in the three months ending on September 30, net profit rose to $5.2 million from $3m. and earnings per diluted share rose to 31 cents from 18 cents. Agrochemicals producer Makhteshim Agan and ECI Telecom continued to increase sales and net profit and the Sheraton Moriah hotel chain made a small net profit for the first time in several years. However, telecommunications network company Telrad and defense company Elisra made losses. Chief Executive Jonathan Kolber said the company was looking to expand its portfolio. "On the investment front, deal flow is strong, and we are actively pursuing several investment directions as a long-term private equity partner," he said. Nine-month net profit rose to $43.5m. from $27.8m. and diluted EPS rose to $2.63 from $1.70.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS